| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein domain specific binding | CACNA1C CABYR TRAF4 TJP1 MTOR SCN5A DBNL ANGEL1 SIGLEC10 RAPGEF1 CIT PLSCR1 PLXNB3 DNM2 | 1.82e-05 | 875 | 85 | 14 | GO:0019904 |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.08e-04 | 22 | 85 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 3.64e-04 | 143 | 85 | 5 | GO:0017124 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 SEMA3F DIP2A FAT4 NPR2 PTPRD MTOR DBNL DNM3 STYXL1 RAPGEF1 ROBO2 EIF2AK4 MAPK9 SULT4A1 WASF1 CIT PLXNB3 DNM2 EPHA8 | 8.13e-08 | 1285 | 81 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB3 SEMA3F DIP2A NPR2 PTPRD DBNL DNM3 ROBO2 EIF2AK4 SULT4A1 WASF1 CIT PLXNB3 DNM2 EPHA8 | 4.58e-07 | 802 | 81 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB3 SEMA3F DIP2A NPR2 PTPRD DBNL DNM3 ROBO2 EIF2AK4 SULT4A1 WASF1 CIT PLXNB3 DNM2 EPHA8 | 5.98e-07 | 819 | 81 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 SEMA3F DIP2A FAT4 NPR2 PTPRD MTOR DBNL DNM3 STYXL1 RAPGEF1 ROBO2 EIF2AK4 MAPK9 SULT4A1 WASF1 CIT PLXNB3 DNM2 EPHA8 | 6.53e-07 | 1463 | 81 | 20 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB3 SEMA3F DIP2A NPR2 PTPRD DBNL DNM3 ROBO2 EIF2AK4 SULT4A1 WASF1 CIT PLXNB3 DNM2 EPHA8 | 6.65e-07 | 826 | 81 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | UNC13B EPHB3 PTPRD NLGN4X TJP1 VPS39 MTOR DBNL CEP135 DNM3 STYXL1 RAPGEF1 ROBO2 MAPK9 PLEKHM1 PLXNB3 DNM2 | 2.94e-06 | 1189 | 81 | 17 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | PTPRD MTOR DBNL CEP135 DNM3 STYXL1 RAPGEF1 ROBO2 PLEKHM1 PLXNB3 DNM2 | 3.56e-06 | 494 | 81 | 11 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB3 SEMA3F PTPRD MTOR DBNL CEP135 DNM3 STYXL1 RAPGEF1 ROBO2 CIT PLEKHM1 PLXNB3 DNM2 | 4.85e-06 | 846 | 81 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB3 SEMA3F PTPRD MTOR DBNL CEP135 DNM3 STYXL1 RAPGEF1 ROBO2 CIT PLEKHM1 PLXNB3 DNM2 | 6.08e-06 | 863 | 81 | 14 | GO:0031344 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 SEMA3F DIP2A NPR2 PTPRD DBNL DNM3 ROBO2 SULT4A1 CIT PLXNB3 DNM2 EPHA8 | 6.52e-06 | 748 | 81 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.29e-05 | 198 | 81 | 7 | GO:0048813 | |
| GeneOntologyBiologicalProcess | synapse organization | UNC13B EPHB3 GABRE SEMA3F DIP2A PTPRD NLGN4X DBNL DNM3 ROBO2 WASF1 PCDH8 | 1.42e-05 | 685 | 81 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | UNC13B GABRE CACNA1C MYOF NPR2 PTPRD NLGN4X EGR3 MTOR EIF2AK4 MAPK9 MYCBPAP NOS1 PCDH8 | 1.43e-05 | 931 | 81 | 14 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | UNC13B GABRE CACNA1C MYOF NPR2 PTPRD NLGN4X EGR3 MTOR EIF2AK4 MAPK9 MYCBPAP NOS1 PCDH8 | 1.43e-05 | 931 | 81 | 14 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | UNC13B GABRE CACNA1C MYOF NPR2 PTPRD NLGN4X EGR3 MTOR EIF2AK4 MAPK9 MYCBPAP NOS1 PCDH8 | 1.58e-05 | 939 | 81 | 14 | GO:0099537 |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 1.67e-05 | 81 | 81 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 1.95e-05 | 141 | 81 | 6 | GO:0060996 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 2.08e-05 | 387 | 81 | 9 | GO:0050807 | |
| GeneOntologyBiologicalProcess | cell junction organization | UNC13B EPHB3 GABRE SEMA3F DIP2A PTPRD NLGN4X TJP1 DBNL DNM3 RAPGEF1 ROBO2 WASF1 PCDH8 | 2.37e-05 | 974 | 81 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | synaptic signaling | UNC13B GABRE CACNA1C MYOF NPR2 PTPRD NLGN4X EGR3 MTOR EIF2AK4 MAPK9 MYCBPAP NOS1 PCDH8 | 2.42e-05 | 976 | 81 | 14 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 2.45e-05 | 395 | 81 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB3 SEMA3F PTPRD MTOR DBNL DNM3 STYXL1 RAPGEF1 ROBO2 CIT PLXNB3 | 2.65e-05 | 612 | 81 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | membrane depolarization during atrial cardiac muscle cell action potential | 4.56e-05 | 3 | 81 | 2 | GO:0098912 | |
| GeneOntologyBiologicalProcess | dendrite development | 5.11e-05 | 335 | 81 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 SEMA3F DIP2A NPR2 PTPRD DBNL DNM3 ROBO2 EIF2AK4 SULT4A1 WASF1 CIT PLXNB3 DNM2 EPHA8 | 5.56e-05 | 1194 | 81 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | UNC13B EPHB3 NPR2 PTPRD MTOR DBNL CEP135 DNM3 STYXL1 RAPGEF1 ROBO2 MAPK9 WASF1 PLEKHM1 PLXNB3 DNM2 | 6.98e-05 | 1366 | 81 | 16 | GO:0051130 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 FAT4 PTPRD NLGN4X EGR3 TJP1 MTOR PCDHGA7 PKD1L1 RAPGEF1 ROBO2 PCDH1 PCDH8 PLXNB3 | 7.08e-05 | 1077 | 81 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 8.51e-05 | 22 | 81 | 3 | GO:1902514 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 9.02e-05 | 115 | 81 | 5 | GO:0097061 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 9.46e-05 | 187 | 81 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 9.76e-05 | 23 | 81 | 3 | GO:0061577 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 1.24e-04 | 123 | 81 | 5 | GO:0120034 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell proliferation | 1.34e-04 | 125 | 81 | 5 | GO:0001938 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 1.44e-04 | 127 | 81 | 5 | GO:0106027 | |
| GeneOntologyBiologicalProcess | response to growth factor | JCAD MYOF FAT4 NPR2 ADAMTS7 EGR3 PIK3CD NFKB1 RAPGEF1 WASF1 NOS1 DNM2 | 1.64e-04 | 883 | 81 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.82e-04 | 301 | 81 | 7 | GO:0048588 | |
| GeneOntologyBiologicalProcess | synapse assembly | 2.09e-04 | 308 | 81 | 7 | GO:0007416 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic anion transport | 2.26e-04 | 6 | 81 | 2 | GO:1903792 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 2.26e-04 | 6 | 81 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.31e-04 | 313 | 81 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 2.31e-04 | 313 | 81 | 7 | GO:0099173 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 3.22e-04 | 438 | 81 | 8 | GO:0032970 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 3.41e-04 | 559 | 81 | 9 | GO:0042391 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 3.88e-04 | 569 | 81 | 9 | GO:0034329 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 4.12e-04 | 37 | 81 | 3 | GO:0086005 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translational initiation | 4.20e-04 | 8 | 81 | 2 | GO:1904688 | |
| GeneOntologyBiologicalProcess | brainstem development | 4.20e-04 | 8 | 81 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 4.35e-04 | 248 | 81 | 6 | GO:0120032 | |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB3 CACNA1C JCAD NCOR2 FAT4 NPR2 EGR3 TJP1 MTOR PIK3CD PKD1L1 SCN5A RAPGEF1 ROBO2 DNM2 | 4.40e-04 | 1442 | 81 | 15 | GO:0072359 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 4.44e-04 | 249 | 81 | 6 | GO:0010976 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 4.55e-04 | 91 | 81 | 4 | GO:0060998 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | 4.57e-04 | 582 | 81 | 9 | GO:0044089 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 4.63e-04 | 251 | 81 | 6 | GO:0060491 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | JCAD MYOF FAT4 ADAMTS7 EGR3 PIK3CD NFKB1 RAPGEF1 WASF1 NOS1 DNM2 | 4.75e-04 | 850 | 81 | 11 | GO:0071363 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | SEMA3F TJP1 MTOR DBNL DNM3 STYXL1 ROBO2 CIT PLSCR1 PLXNB3 DNM2 | 5.44e-04 | 864 | 81 | 11 | GO:0051129 |
| GeneOntologyBiologicalProcess | lamellipodium organization | 6.26e-04 | 99 | 81 | 4 | GO:0097581 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 6.72e-04 | 10 | 81 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 6.74e-04 | 747 | 81 | 10 | GO:0007169 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 6.80e-04 | 270 | 81 | 6 | GO:0050679 | |
| GeneOntologyBiologicalProcess | cytoplasmic translational initiation | 7.35e-04 | 45 | 81 | 3 | GO:0002183 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium assembly | 7.35e-04 | 45 | 81 | 3 | GO:0010591 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 7.60e-04 | 625 | 81 | 9 | GO:0051960 | |
| GeneOntologyBiologicalProcess | antibacterial innate immune response | 8.19e-04 | 11 | 81 | 2 | GO:0140367 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 8.19e-04 | 11 | 81 | 2 | GO:0016185 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 8.21e-04 | 280 | 81 | 6 | GO:1902115 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 9.32e-04 | 515 | 81 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1C NLGN4X SLC15A2 SCN5A DBNL DNM3 RAPGEF1 MYCBPAP WASF1 NOS1 PLSCR1 DNM2 | 9.52e-04 | 1074 | 81 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 9.59e-04 | 192 | 81 | 5 | GO:0050770 | |
| GeneOntologyBiologicalProcess | autophagosome-lysosome fusion | 9.80e-04 | 12 | 81 | 2 | GO:0061909 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 9.80e-04 | 12 | 81 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 9.80e-04 | 12 | 81 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 9.94e-04 | 112 | 81 | 4 | GO:0006809 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.15e-03 | 663 | 81 | 9 | GO:0050804 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 1.15e-03 | 299 | 81 | 6 | GO:0060560 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.16e-03 | 13 | 81 | 2 | GO:0097090 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.16e-03 | 664 | 81 | 9 | GO:0099177 | |
| GeneOntologyBiologicalProcess | action potential | 1.18e-03 | 201 | 81 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 1.19e-03 | 53 | 81 | 3 | GO:1903115 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 1.32e-03 | 121 | 81 | 4 | GO:0046209 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.34e-03 | 207 | 81 | 5 | GO:1990138 | |
| GeneOntologyBiologicalProcess | regulation of Fc receptor mediated stimulatory signaling pathway | 1.34e-03 | 14 | 81 | 2 | GO:0060368 | |
| GeneOntologyBiologicalProcess | cellular response to brain-derived neurotrophic factor stimulus | 1.34e-03 | 14 | 81 | 2 | GO:1990416 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.36e-03 | 309 | 81 | 6 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell proliferation | 1.37e-03 | 208 | 81 | 5 | GO:0001936 | |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 1.41e-03 | 123 | 81 | 4 | GO:2001057 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium organization | 1.47e-03 | 57 | 81 | 3 | GO:1902743 | |
| GeneOntologyBiologicalProcess | cellular response to peptide | 1.55e-03 | 15 | 81 | 2 | GO:1901653 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 1.55e-03 | 15 | 81 | 2 | GO:0070142 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.55e-03 | 15 | 81 | 2 | GO:0086067 | |
| GeneOntologyBiologicalProcess | cellular response to nerve growth factor stimulus | 1.62e-03 | 59 | 81 | 3 | GO:1990090 | |
| GeneOntologyBiologicalProcess | developmental maturation | 1.69e-03 | 439 | 81 | 7 | GO:0021700 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.70e-03 | 566 | 81 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | Rac protein signal transduction | 1.70e-03 | 60 | 81 | 3 | GO:0016601 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 1.78e-03 | 61 | 81 | 3 | GO:0003254 | |
| GeneOntologyBiologicalProcess | response to nerve growth factor | 1.78e-03 | 61 | 81 | 3 | GO:1990089 | |
| GeneOntologyCellularComponent | glutamatergic synapse | UNC13B SEMA3F CACNA1C DIP2A PTPRD NLGN4X MTOR DBNL DNM3 ROBO2 NOS1 PCDH8 DNM2 | 2.47e-05 | 817 | 85 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | neuron to neuron synapse | 5.14e-05 | 523 | 85 | 10 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynapse | GABRE CACNA1C DIP2A NLGN4X MTOR DBNL DNM3 ROBO2 EIF3A WASF1 KIF17 NOS1 PCDH8 DNM2 | 5.79e-05 | 1018 | 85 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | synaptic membrane | UNC13B GABRE CACNA1C PTPRD NLGN4X DBNL DNM3 ROBO2 PCDH8 DNM2 | 1.26e-04 | 583 | 85 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | dendrite | EPHB3 GABRE CACNA1C DIP2A NLGN4X MTOR DBNL DNM3 KIF17 NOS1 PCDH8 EPHA8 | 1.77e-04 | 858 | 85 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB3 GABRE CACNA1C DIP2A NLGN4X MTOR DBNL DNM3 KIF17 NOS1 PCDH8 EPHA8 | 1.81e-04 | 860 | 85 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.43e-04 | 405 | 85 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.89e-04 | 78 | 85 | 4 | GO:0001917 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB3 GABRE CACNA1C DIP2A NLGN4X MTOR DBNL DNM3 MAPK9 KIF17 CIT NOS1 PCDH8 EPHA8 | 4.08e-04 | 1228 | 85 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | phagocytic vesicle | 4.53e-04 | 157 | 85 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | postsynaptic density | 4.97e-04 | 451 | 85 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | podosome | 6.19e-04 | 41 | 85 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.17e-04 | 477 | 85 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.01e-03 | 503 | 85 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | caveola | 1.10e-03 | 111 | 85 | 4 | GO:0005901 | |
| MousePheno | decreased skeletal muscle weight | 7.89e-06 | 24 | 76 | 4 | MP:0010239 | |
| MousePheno | abnormal skeletal muscle weight | 1.73e-05 | 29 | 76 | 4 | MP:0010237 | |
| MousePheno | decreased muscle weight | 3.31e-05 | 34 | 76 | 4 | MP:0004232 | |
| MousePheno | decreased skeletal muscle mass | 7.71e-05 | 131 | 76 | 6 | MP:0004819 | |
| MousePheno | decreased skeletal muscle size | 7.72e-05 | 81 | 76 | 5 | MP:0010240 | |
| MousePheno | abnormal muscle weight | 9.29e-05 | 44 | 76 | 4 | MP:0004233 | |
| MousePheno | abnormal skeletal muscle size | 1.49e-04 | 93 | 76 | 5 | MP:0009458 | |
| MousePheno | abnormal skeletal muscle mass | 1.57e-04 | 149 | 76 | 6 | MP:0004817 | |
| Domain | Kinase-like_dom | EPHB3 NPR2 MTOR PIK3CD SIK2 DNM3 EIF2AK4 MAPK9 CIT DNM2 EPHA8 | 3.40e-05 | 542 | 85 | 11 | IPR011009 |
| Domain | Fumarylacetoacetase_C-rel | 1.22e-04 | 4 | 85 | 2 | IPR011234 | |
| Domain | FAA_hydrolase | 1.22e-04 | 4 | 85 | 2 | PF01557 | |
| Domain | - | 1.22e-04 | 4 | 85 | 2 | 3.90.850.10 | |
| Domain | DMAP_binding | 2.03e-04 | 5 | 85 | 2 | PF06464 | |
| Domain | Dynamin_central | 3.03e-04 | 6 | 85 | 2 | IPR000375 | |
| Domain | GED | 3.03e-04 | 6 | 85 | 2 | SM00302 | |
| Domain | GED | 3.03e-04 | 6 | 85 | 2 | PS51388 | |
| Domain | DMAP1-bd | 3.03e-04 | 6 | 85 | 2 | IPR010506 | |
| Domain | Dynamin_M | 3.03e-04 | 6 | 85 | 2 | PF01031 | |
| Domain | Dynamin_GTPase_CS | 3.03e-04 | 6 | 85 | 2 | IPR019762 | |
| Domain | GED_dom | 3.03e-04 | 6 | 85 | 2 | IPR020850 | |
| Domain | GED | 3.03e-04 | 6 | 85 | 2 | PF02212 | |
| Domain | GED | 3.03e-04 | 6 | 85 | 2 | IPR003130 | |
| Domain | DMAP_binding | 3.03e-04 | 6 | 85 | 2 | SM01137 | |
| Domain | AMP-binding | 3.38e-04 | 30 | 85 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 3.38e-04 | 30 | 85 | 3 | IPR000873 | |
| Domain | G_DYNAMIN_1 | 4.24e-04 | 7 | 85 | 2 | PS00410 | |
| Domain | DYNc | 4.24e-04 | 7 | 85 | 2 | SM00053 | |
| Domain | Cadherin_CS | 1.55e-03 | 109 | 85 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 1.76e-03 | 113 | 85 | 4 | PS00232 | |
| Domain | Cadherin | 1.76e-03 | 113 | 85 | 4 | PF00028 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.80e-03 | 14 | 85 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.80e-03 | 14 | 85 | 2 | PS00790 | |
| Domain | Eph_TM | 1.80e-03 | 14 | 85 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.80e-03 | 14 | 85 | 2 | IPR001426 | |
| Domain | EPH_lbd | 1.80e-03 | 14 | 85 | 2 | SM00615 | |
| Domain | G_DYNAMIN_dom | 1.80e-03 | 14 | 85 | 2 | IPR030381 | |
| Domain | Ephrin_lbd | 1.80e-03 | 14 | 85 | 2 | PF01404 | |
| Domain | EphA2_TM | 1.80e-03 | 14 | 85 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.80e-03 | 14 | 85 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.80e-03 | 14 | 85 | 2 | IPR001090 | |
| Domain | EPH_LBD | 1.80e-03 | 14 | 85 | 2 | PS51550 | |
| Domain | CNH | 1.80e-03 | 14 | 85 | 2 | SM00036 | |
| Domain | G_DYNAMIN_2 | 1.80e-03 | 14 | 85 | 2 | PS51718 | |
| Domain | CADHERIN_2 | 1.82e-03 | 114 | 85 | 4 | PS50268 | |
| Domain | - | 1.82e-03 | 114 | 85 | 4 | 2.60.40.60 | |
| Domain | CA | 1.88e-03 | 115 | 85 | 4 | SM00112 | |
| Domain | Cadherin-like | 1.94e-03 | 116 | 85 | 4 | IPR015919 | |
| Domain | SAM/pointed | 2.00e-03 | 117 | 85 | 4 | IPR013761 | |
| Domain | Cadherin | 2.07e-03 | 118 | 85 | 4 | IPR002126 | |
| Domain | Dynamin_GTPase | 2.07e-03 | 15 | 85 | 2 | IPR001401 | |
| Domain | Dynamin_N | 2.07e-03 | 15 | 85 | 2 | PF00350 | |
| Domain | CNH | 2.07e-03 | 15 | 85 | 2 | PF00780 | |
| Domain | Dynamin_SF | 2.07e-03 | 15 | 85 | 2 | IPR022812 | |
| Domain | CNH | 2.07e-03 | 15 | 85 | 2 | PS50219 | |
| Domain | CNH_dom | 2.07e-03 | 15 | 85 | 2 | IPR001180 | |
| Domain | PI3/4_kinase_CS | 2.07e-03 | 15 | 85 | 2 | IPR018936 | |
| Domain | - | 2.36e-03 | 16 | 85 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.36e-03 | 16 | 85 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 2.99e-03 | 18 | 85 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.99e-03 | 18 | 85 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.99e-03 | 18 | 85 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.99e-03 | 18 | 85 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.99e-03 | 18 | 85 | 2 | PS00916 | |
| Domain | ZF_DAG_PE_1 | 3.10e-03 | 64 | 85 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.10e-03 | 64 | 85 | 3 | PS50081 | |
| Domain | - | EPHB3 SEMA3F PTPRD NFKB1 CD300LB SIGLEC10 ROBO2 PLXNB3 EPHA8 | 3.16e-03 | 663 | 85 | 9 | 2.60.40.10 |
| Domain | C1 | 3.24e-03 | 65 | 85 | 3 | SM00109 | |
| Domain | Cadherin_2 | 3.24e-03 | 65 | 85 | 3 | PF08266 | |
| Domain | Cadherin_N | 3.24e-03 | 65 | 85 | 3 | IPR013164 | |
| Domain | PLAC | 3.33e-03 | 19 | 85 | 2 | PS50900 | |
| Domain | PLAC | 3.33e-03 | 19 | 85 | 2 | IPR010909 | |
| Domain | PE/DAG-bd | 3.39e-03 | 66 | 85 | 3 | IPR002219 | |
| Domain | - | 4.50e-03 | 73 | 85 | 3 | 2.60.120.260 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 1.30e-05 | 11 | 62 | 3 | M47791 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 5.25e-05 | 47 | 62 | 4 | M19708 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 1.03e-04 | 431 | 62 | 9 | M39729 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 1.74e-04 | 119 | 62 | 5 | M48309 | |
| Pathway | WP_IL5_SIGNALING_PATHWAY | 2.24e-04 | 68 | 62 | 4 | MM15930 | |
| Pathway | KEGG_AXON_GUIDANCE | 2.53e-04 | 129 | 62 | 5 | M5539 | |
| Pathway | PID_NEPHRIN_NEPH1_PATHWAY | 3.34e-04 | 31 | 62 | 3 | M193 | |
| Pathway | PID_IL2_PI3K_PATHWAY | 4.40e-04 | 34 | 62 | 3 | M143 | |
| Pathway | SIG_CD40PATHWAYMAP | 4.40e-04 | 34 | 62 | 3 | M12705 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 5.24e-04 | 8 | 62 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 5.24e-04 | 8 | 62 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 5.24e-04 | 8 | 62 | 2 | M47715 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 5.75e-04 | 87 | 62 | 4 | MM15915 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 6.26e-04 | 89 | 62 | 4 | M39732 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 6.72e-04 | 9 | 62 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 6.72e-04 | 9 | 62 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 6.72e-04 | 9 | 62 | 2 | M47481 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES | 6.72e-04 | 9 | 62 | 2 | M47777 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 8.33e-04 | 96 | 62 | 4 | M16121 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 8.37e-04 | 10 | 62 | 2 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES | 8.37e-04 | 10 | 62 | 2 | M47776 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 8.63e-04 | 575 | 62 | 9 | M29853 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 9.44e-04 | 44 | 62 | 3 | M175 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 9.70e-04 | 100 | 62 | 4 | MM15879 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 9.82e-04 | 261 | 62 | 6 | M42565 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 9.82e-04 | 261 | 62 | 6 | MM15676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 1.02e-03 | 11 | 62 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 1.02e-03 | 11 | 62 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.02e-03 | 11 | 62 | 2 | M47499 | |
| Pathway | WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS | 1.02e-03 | 11 | 62 | 2 | M39871 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.02e-03 | 11 | 62 | 2 | M47501 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 1.14e-03 | 47 | 62 | 3 | M39380 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.22e-03 | 12 | 62 | 2 | M47393 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 1.22e-03 | 12 | 62 | 2 | M45559 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 1.29e-03 | 108 | 62 | 4 | M48078 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 1.37e-03 | 50 | 62 | 3 | M39822 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 1.44e-03 | 13 | 62 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 1.44e-03 | 13 | 62 | 2 | M47603 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 1.45e-03 | 51 | 62 | 3 | M39457 | |
| Pathway | WP_GASTRIN_SIGNALING | 1.63e-03 | 115 | 62 | 4 | M39866 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 1.67e-03 | 14 | 62 | 2 | M10122 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.67e-03 | 14 | 62 | 2 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.67e-03 | 14 | 62 | 2 | M47536 | |
| Pathway | WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS | 1.67e-03 | 14 | 62 | 2 | M45553 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 1.71e-03 | 54 | 62 | 3 | M39435 | |
| Pathway | WP_RANKLRANK_SIGNALING | 1.81e-03 | 55 | 62 | 3 | M39667 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 1.93e-03 | 15 | 62 | 2 | M47663 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.93e-03 | 15 | 62 | 2 | M47475 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 2.00e-03 | 57 | 62 | 3 | M19888 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE | 2.02e-03 | 122 | 62 | 4 | MM14640 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 UNC13B SEMA3F NCOR2 DIP2A MYOF TRAF4 ADAMTS7 VPS39 MTOR PIK3CD SCN5A DIP2C RAPGEF1 LRBA TMEM127 CIT PLEKHM1 | 1.54e-10 | 1105 | 85 | 18 | 35748872 |
| Pubmed | UNC13B JCAD DIP2A PTPRD ERG TJP1 VPS39 DNM3 LRBA SULT4A1 CIT PLXNB3 DNM2 ZNF292 | 2.70e-06 | 1285 | 85 | 14 | 35914814 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 33860440 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18508038 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18573890 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20299603 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12137943 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22886792 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30190183 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17405917 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23216249 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22505595 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36672142 | ||
| Pubmed | Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. | 5.90e-06 | 2 | 85 | 2 | 25341504 | |
| Pubmed | Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. | 5.90e-06 | 2 | 85 | 2 | 22145100 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34547324 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24735948 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22217202 | ||
| Pubmed | Differential expression of murine CGI-105 gene in 3T3-L1 cells by adrenocorticotropic hormones. | 5.90e-06 | 2 | 85 | 2 | 15774318 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20942845 | ||
| Pubmed | Discordant regulation of eIF2 kinase GCN2 and mTORC1 during nutrient stress. | 5.90e-06 | 2 | 85 | 2 | 34023907 | |
| Pubmed | Dynamin-2 is a novel NOS1β interacting protein and negative regulator in the collecting duct. | 5.90e-06 | 2 | 85 | 2 | 26791826 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21113813 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22808170 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 33760196 | ||
| Pubmed | Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. | 9.35e-06 | 17 | 85 | 3 | 12023963 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | DIP2A TMPRSS15 FAHD2B PTPRD MTOR NFKB1 FAHD2A TMEM127 CIT DCBLD2 GIMAP6 PLSCR1 PLXNB3 | 9.80e-06 | 1242 | 85 | 13 | 30973865 |
| Pubmed | 1.05e-05 | 117 | 85 | 5 | 17145500 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GABRE CACNA1C NCOR2 UBE2H TJP1 RBM6 STAP2 DIP2C ZFHX2 STYXL1 EIF2AK4 LRBA PCDH1 PLEKHM1 | 1.44e-05 | 1489 | 85 | 14 | 28611215 |
| Pubmed | 1.56e-05 | 754 | 85 | 10 | 35906200 | ||
| Pubmed | Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes. | 1.77e-05 | 3 | 85 | 2 | 19013287 | |
| Pubmed | Genetic analysis of the role of Eph receptors in the development of the mammalian nervous system. | 1.77e-05 | 3 | 85 | 2 | 9321682 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20406817 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25759478 | ||
| Pubmed | Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity. | 1.77e-05 | 3 | 85 | 2 | 28552773 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12511974 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17236128 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 26206180 | ||
| Pubmed | A universal metabolite repair enzyme removes a strong inhibitor of the TCA cycle. | 1.77e-05 | 3 | 85 | 2 | 38287013 | |
| Pubmed | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 1.77e-05 | 3 | 85 | 2 | 32573516 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16285952 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 35276460 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25509983 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23444213 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18675932 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12383797 | ||
| Pubmed | Infectious tolerance via the consumption of essential amino acids and mTOR signaling. | 1.77e-05 | 3 | 85 | 2 | 19567830 | |
| Pubmed | Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A. | 1.77e-05 | 3 | 85 | 2 | 23541953 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 24273169 | ||
| Pubmed | Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor. | 1.77e-05 | 3 | 85 | 2 | 25043302 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 26752047 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 1.77e-05 | 3 | 85 | 2 | 28395327 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22509023 | ||
| Pubmed | Attenuation of canonical NF-κB signaling maintains function and stability of human Treg. | 1.77e-05 | 3 | 85 | 2 | 32386462 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12517701 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 21933813 | ||
| Pubmed | T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation. | 1.77e-05 | 3 | 85 | 2 | 23091043 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16397145 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 21884682 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 1.77e-05 | 3 | 85 | 2 | 24046449 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25898924 | ||
| Pubmed | Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. | 3.53e-05 | 4 | 85 | 2 | 17912374 | |
| Pubmed | The LKB1-SIK Pathway Controls Dendrite Self-Avoidance in Purkinje Cells. | 3.53e-05 | 4 | 85 | 2 | 30208308 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 27486771 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 24687990 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 3.53e-05 | 4 | 85 | 2 | 21689597 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18591664 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 22846998 | ||
| Pubmed | Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer. | 3.53e-05 | 4 | 85 | 2 | 25738361 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 37909722 | ||
| Pubmed | The tight junction protein TJP1 regulates the feeding-modulated hepatic circadian clock. | 3.53e-05 | 4 | 85 | 2 | 32001717 | |
| Pubmed | Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. | 3.53e-05 | 4 | 85 | 2 | 17702744 | |
| Pubmed | TLR4 inhibited autophagy by modulating PI3K/AKT/mTOR signaling pathway in Gastric cancer cell lines. | 3.53e-05 | 4 | 85 | 2 | 37257791 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21343542 | ||
| Pubmed | mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells. | 3.53e-05 | 4 | 85 | 2 | 23538752 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17400176 | ||
| Pubmed | 3.59e-05 | 371 | 85 | 7 | 15747579 | ||
| Pubmed | 3.95e-05 | 27 | 85 | 3 | 19723784 | ||
| Pubmed | JCAD NCOR2 PTPRD TJP1 NFKB1 CEP135 STYXL1 UBR3 EIF2AK4 MAPK9 WASF1 | 4.96e-05 | 1049 | 85 | 11 | 27880917 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 25589557 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 30862798 | ||
| Pubmed | ENaC is regulated by natriuretic peptide receptor-dependent cGMP signaling. | 5.87e-05 | 5 | 85 | 2 | 23324181 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 9722593 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 14704277 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 18715846 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 6.98e-05 | 560 | 85 | 8 | 21653829 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 7.03e-05 | 283 | 85 | 6 | 18854154 | |
| Pubmed | The endolysosomal adaptor PLEKHM1 is a direct target for both mTOR and MAPK pathways. | 7.29e-05 | 33 | 85 | 3 | 33452816 | |
| Pubmed | DHHC protein family targets different subsets of glioma stem cells in specific niches. | 7.29e-05 | 33 | 85 | 3 | 30658672 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 23640057 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 23183047 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 27251629 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 10777532 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 19097143 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 22351125 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 18602423 | ||
| Pubmed | Nano-scale architecture of blood-brain barrier tight-junctions. | 8.80e-05 | 6 | 85 | 2 | 34951586 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 19506035 | ||
| Pubmed | 1.12e-04 | 38 | 85 | 3 | 25613138 | ||
| Pubmed | 1.21e-04 | 963 | 85 | 10 | 28671696 | ||
| Interaction | TOP3B interactions | VWA5B2 UNC13B SEMA3F NCOR2 DIP2A MYOF TRAF4 ADAMTS7 RBM33 VPS39 MTOR PIK3CD SCN5A DIP2C RAPGEF1 LRBA TMEM127 CIT TFCP2 PLEKHM1 | 1.53e-06 | 1470 | 83 | 20 | int:TOP3B |
| Cytoband | 1p36.2 | 2.61e-04 | 13 | 85 | 2 | 1p36.2 | |
| Cytoband | 10p15.3 | 3.04e-04 | 14 | 85 | 2 | 10p15.3 | |
| Cytoband | 2q11.2 | 3.33e-04 | 72 | 85 | 3 | 2q11.2 | |
| Cytoband | 12q24 | 9.89e-04 | 25 | 85 | 2 | 12q24 | |
| Cytoband | 1p36.12 | 2.40e-03 | 39 | 85 | 2 | 1p36.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 2.94e-03 | 153 | 85 | 3 | chr2q11 | |
| Cytoband | 15q15.1 | 3.47e-03 | 47 | 85 | 2 | 15q15.1 | |
| GeneFamily | Non-clustered protocadherins | 6.10e-04 | 12 | 56 | 2 | 21 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 8.37e-04 | 14 | 56 | 2 | 1095 | |
| GeneFamily | Fibronectin type III domain containing | 1.52e-03 | 160 | 56 | 4 | 555 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.56e-03 | 19 | 56 | 2 | 50 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | UNC13B EPHB3 GABRE DIP2A NPR2 PTPRD ADAMTS7 TJP1 ZFHX2 EIF3A LRBA TOX2 CIT GIMAP6 ZNF292 | 7.72e-06 | 986 | 85 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.97e-08 | 182 | 85 | 7 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.68e-08 | 185 | 85 | 7 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.68e-08 | 185 | 85 | 7 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.01e-08 | 190 | 85 | 7 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-08 | 194 | 85 | 7 | df56e23f1dcf1902d29392fcc947e0e268e1648b | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-07 | 170 | 85 | 6 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-07 | 170 | 85 | 6 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-07 | 170 | 85 | 6 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.74e-07 | 172 | 85 | 6 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-06 | 180 | 85 | 6 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 1.54e-06 | 186 | 85 | 6 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.58e-06 | 187 | 85 | 6 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.74e-06 | 190 | 85 | 6 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.74e-06 | 190 | 85 | 6 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-06 | 192 | 85 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-06 | 193 | 85 | 6 | b6b065b0c2ad31d1488dfa970450b29a8ac1f3aa | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-06 | 193 | 85 | 6 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-06 | 193 | 85 | 6 | 4513e6cb3f86d9cc56e7892fbe11a861335bd179 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-06 | 193 | 85 | 6 | ee4b31d9c92f8fd0d3ddb5e723b82300fcb459d1 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-06 | 193 | 85 | 6 | 30254658a2023ea9808cdd786530b966a1446418 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.90e-06 | 193 | 85 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-06 | 193 | 85 | 6 | 7401e276b644b254c692160d0e7417ec28d50aa4 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-06 | 194 | 85 | 6 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-06 | 194 | 85 | 6 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 194 | 85 | 6 | e30a3765feae5cd10ddba16a166c31eb5717edd3 | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.96e-06 | 194 | 85 | 6 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-06 | 194 | 85 | 6 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | facs-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-06 | 194 | 85 | 6 | 3b5ba12375102598468cb09e66af9241b66c3cf9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 195 | 85 | 6 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 195 | 85 | 6 | e5f14f6015ea5e6fa065f906ad22157e3de15c68 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 195 | 85 | 6 | 5b84fd5be31386eb1d6048bbf28626032361842e | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 195 | 85 | 6 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 196 | 85 | 6 | f6df26ab9eebae893768a4f70a064ce9f60da93c | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.08e-06 | 196 | 85 | 6 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | facs-Lung-ENDOMUCIN|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 196 | 85 | 6 | 69f03546c42c942ab8ac8746167c8d44d574b4c6 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-06 | 197 | 85 | 6 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-06 | 197 | 85 | 6 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | f701d06e3d7fd2192afae3698c5ec3c355e96da3 | |
| ToppCell | Endothelial-A|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-06 | 198 | 85 | 6 | dd096d4b9f428615f927f7df7cbf5cede0e0e605 | |
| ToppCell | proximal-3-Endothelial-Artery|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | 946f72b594d22ae7b8e4c22483814c284cb43eea | |
| ToppCell | distal-Endothelial-Artery-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | f284f59f4ebe55ee132eddfaa2f5d9ecb059654f | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.21e-06 | 198 | 85 | 6 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | proximal-Endothelial-Artery|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | 0e5572298676b6c2a2b1a77967574020b664aebd | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-06 | 198 | 85 | 6 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | proximal-Endothelial-Artery-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | a56b80bdc824e4cc60366f273fb616cd0efec456 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 1.76e-05 | 168 | 85 | 5 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-05 | 171 | 85 | 5 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 173 | 85 | 5 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 173 | 85 | 5 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.14e-05 | 175 | 85 | 5 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-05 | 177 | 85 | 5 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 177 | 85 | 5 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 179 | 85 | 5 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 179 | 85 | 5 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 181 | 85 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.52e-05 | 181 | 85 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 182 | 85 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.73e-05 | 184 | 85 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 186 | 85 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 186 | 85 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-05 | 186 | 85 | 5 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 186 | 85 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.95e-05 | 187 | 85 | 5 | e9aa0a5a0f8e2593de63e83b56b53ae33e60af49 | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.95e-05 | 187 | 85 | 5 | da885c26ccc5189b1ff1f607552e00a5c0e49e7e | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.95e-05 | 187 | 85 | 5 | 61b8a53f29bb8b33c69f680b8359a1143a23999d | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 2.95e-05 | 187 | 85 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.95e-05 | 187 | 85 | 5 | 1f358d02ec69d44dea2e2831af9473ed05dcf8cc | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 188 | 85 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-05 | 188 | 85 | 5 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 189 | 85 | 5 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 3.10e-05 | 189 | 85 | 5 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 189 | 85 | 5 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 189 | 85 | 5 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | 1ff2295c9fc94ea21fff286706b739d0deb032d0 | |
| ToppCell | Endothelial-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 190 | 85 | 5 | 6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | 61f2f9fb4b8f47a2a669f6b052214d2ce0c194cd | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 190 | 85 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | E17.5-Endothelial|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.18e-05 | 190 | 85 | 5 | 4fb76195ec9d6e0260a628eef6c2b3705acce787 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-05 | 190 | 85 | 5 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | d415c8f3d69a8142e95307aeabc6d0e812cd5165 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.26e-05 | 191 | 85 | 5 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 191 | 85 | 5 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.26e-05 | 191 | 85 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-05 | 191 | 85 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 191 | 85 | 5 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.26e-05 | 191 | 85 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-05 | 191 | 85 | 5 | 2b427741a58921e161101a282d1fe526cd9e760d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 192 | 85 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 192 | 85 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | facs-Lung-Endomucin_-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | ba3fe97786564dba1c8185f2802ce1b57f4f3cc9 | |
| ToppCell | facs-Lung-Endomucin_|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | 85d4d0df701451daf95e94a87a0096da1e86533b | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | be75783d9578974b662e1cb13bd3442a921fd50a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 192 | 85 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | 4fc98f30f8e738816cd93101fbe8ac40889e302a | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 192 | 85 | 5 | 3c8603f977de34ee0d2bb50635f6722112a6a4db | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.42e-05 | 193 | 85 | 5 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| Drug | N-methyl-DL-aspartic acid | EPHB3 GABRE CACNA1C NPR2 MTOR PIK3CD NFKB1 HSH2D LRBA MAPK9 KIF17 CIT NOS1 | 9.06e-07 | 655 | 85 | 13 | CID000004376 |
| Drug | delphinidin | 4.00e-06 | 29 | 85 | 4 | CID000068245 | |
| Drug | 5'-GMP Na2 | 4.48e-06 | 335 | 85 | 9 | CID000000761 | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 8.81e-06 | 196 | 85 | 7 | 3369_UP | |
| Drug | CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A | 1.00e-05 | 200 | 85 | 7 | 7082_UP | |
| Drug | DB04649 | 1.95e-05 | 148 | 85 | 6 | CID005287847 | |
| Disease | corneal topography | 1.45e-05 | 109 | 83 | 5 | EFO_0004345 | |
| Disease | pulmonary venoocclusive disease (is_marker_for) | 4.67e-05 | 4 | 83 | 2 | DOID:5453 (is_marker_for) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 7.77e-05 | 5 | 83 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 7.77e-05 | 5 | 83 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 7.77e-05 | 5 | 83 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | pulmonary venoocclusive disease (biomarker_via_orthology) | 1.63e-04 | 7 | 83 | 2 | DOID:5453 (biomarker_via_orthology) | |
| Disease | Brugada syndrome | 2.16e-04 | 8 | 83 | 2 | cv:C1142166 | |
| Disease | R-6-hydroxywarfarin measurement | 3.07e-04 | 114 | 83 | 4 | EFO_0803327 | |
| Disease | Lymphoma, Lymphocytic, Intermediate | 4.23e-04 | 11 | 83 | 2 | C0751958 | |
| Disease | RS-warfarin measurement | 4.76e-04 | 128 | 83 | 4 | EFO_0803325 | |
| Disease | collagen disease (implicated_via_orthology) | 5.07e-04 | 12 | 83 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Common variable immunodeficiency | 5.98e-04 | 13 | 83 | 2 | cv:C0009447 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 5.98e-04 | 13 | 83 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 6.96e-04 | 14 | 83 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | Autistic Disorder | 8.63e-04 | 261 | 83 | 5 | C0004352 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 9.14e-04 | 16 | 83 | 2 | C0334634 | |
| Disease | frontal pole volume measurement | 1.16e-03 | 18 | 83 | 2 | EFO_0010304 | |
| Disease | epilepsy (implicated_via_orthology) | 1.17e-03 | 163 | 83 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | portal hypertension (implicated_via_orthology) | 1.30e-03 | 19 | 83 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | multiple sclerosis | 1.43e-03 | 594 | 83 | 7 | MONDO_0005301 | |
| Disease | end stage renal disease (implicated_via_orthology) | 1.44e-03 | 20 | 83 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | corneal resistance factor | 1.73e-03 | 451 | 83 | 6 | EFO_0010067 | |
| Disease | Primary microcephaly | 1.74e-03 | 22 | 83 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.74e-03 | 22 | 83 | 2 | C3711387 | |
| Disease | central corneal thickness | 1.82e-03 | 309 | 83 | 5 | EFO_0005213 | |
| Disease | Attention deficit hyperactivity disorder | 2.07e-03 | 24 | 83 | 2 | C1263846 | |
| Disease | Brugada Syndrome (disorder) | 2.07e-03 | 24 | 83 | 2 | C1142166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EYQDQRPPLDQPLEL | 551 | Q9NWW7 | |
| GKPLPPYIVQIVDEN | 391 | Q6P461 | |
| EPPEINLVLYPQGLT | 51 | Q9P2K8 | |
| PQNPLGDVYSPEELQ | 256 | Q96QU6 | |
| PKTEDQRPQLDPYQI | 281 | P11308 | |
| EGNPKPDIIERENPY | 4576 | Q6V0I7 | |
| YAVELEGQQPISVPP | 176 | P30038 | |
| SVPLQDEQEPPAYDQ | 261 | O75952 | |
| PPNPEYQEFQNRLLI | 301 | P20594 | |
| EDPALPTQVPLQYNE | 1246 | O14578 | |
| YNNLTNVEGRIEPPP | 1096 | O95450 | |
| EQTPGNPLINFLPEE | 1146 | Q9UKP4 | |
| QQQLYAPPPPAEQEE | 831 | Q96EV2 | |
| FVLDQNDNPPEILYP | 551 | Q9Y5G6 | |
| EAPPPQIYDAQLEER | 331 | P45984 | |
| EGLGPQVELPLYNQP | 246 | Q9Y618 | |
| YTDENIQEGLAPKPP | 21 | O43513 | |
| QNIPNPYLEDTVPIN | 351 | Q9P266 | |
| YIQPICLPEENQVFP | 891 | P98073 | |
| TKVPVGDQPPDIEYQ | 141 | Q9UQ16 | |
| QEIEIQAPPGVPIGY | 191 | O15162 | |
| NVQLALGPVQYEAEP | 1231 | Q9ULL4 | |
| VYKVPEEQPPNTLIG | 61 | Q08174 | |
| LPDLQEIGVPLYQSP | 1041 | O95206 | |
| QDQPYQLPVEIDPLI | 2561 | P50851 | |
| DVINAVEQDYRLPPP | 846 | P54753 | |
| VVYGPQPQPLENQLL | 36 | P78334 | |
| VGPYDEVVLPPQSQE | 141 | Q96GK7 | |
| TKVPVGDQPPDIEYQ | 141 | P50570 | |
| EPENDQLPEEYQQPP | 331 | Q96JZ2 | |
| ANGNDPELFQIPPEL | 531 | P29475 | |
| PVPQPDDPYIADLLQ | 186 | Q66GS9 | |
| PAIVYANQEVPPPVE | 401 | Q8N6G5 | |
| LGIPLEEVPPEEINY | 116 | Q13907 | |
| LQPNENEDKSPYPNP | 826 | Q13936 | |
| EQPEKEPELQQYVPQ | 416 | Q14152 | |
| VGPYDEVVLPPQSQE | 141 | Q6P2I3 | |
| LLNQLPDNLYPEEIP | 16 | Q06889 | |
| QLLPPELYNPNFQEE | 486 | Q9H972 | |
| QEPEQPNGIILEYEI | 461 | P29322 | |
| FEELLEVQQPDPNQP | 281 | Q9Y2E4 | |
| GLPAPDELVYQVPQS | 741 | Q96PD2 | |
| FEELLEVQQPDPNQP | 296 | Q14689 | |
| IYNKPPPEGNIVAQV | 241 | Q16348 | |
| QLIIENPPINIPHGY | 746 | Q68D06 | |
| PLPNEILGPVEQYLG | 61 | Q8N0W4 | |
| VGGPENPYLIDPENQ | 2411 | Q8TDX9 | |
| EPPEQETFYEQPPLV | 336 | Q9UJU6 | |
| QPPPVEKQNGIITEY | 631 | P23468 | |
| GEQNYLPQEEPQEVP | 591 | Q9P2E2 | |
| LELAVPGTYDPNQPI | 2136 | P42345 | |
| VNVQYPDQPEEPPEA | 636 | Q9Y4G2 | |
| PPNIEKPQEAPEYQE | 161 | Q8N8U3 | |
| NTQQEVYVPQDPGLP | 811 | P78332 | |
| PPLPNQEENYVTPIG | 301 | Q9UGK3 | |
| PYQELAQLLAQPEVG | 726 | Q13275 | |
| YEQIPQENPPEELSQ | 6 | Q6P9H5 | |
| DLYGNPPQELIGEPL | 66 | Q14524 | |
| PVQRPVLYPQEQENE | 276 | Q9H0K1 | |
| KNQQEIPSYLNDEPP | 6 | Q8WUH6 | |
| EGLGQLQPPAVEIPY | 201 | Q9UNK9 | |
| QRVPEEPGEQPIYMN | 176 | A8K4G0 | |
| EYVQPICLPEPNFNL | 96 | Q7RTY3 | |
| QLLAYPNPIDPLNGD | 111 | P62256 | |
| LVIQYNEGKQAVPPP | 1451 | Q9C0A1 | |
| QELDAFQPYPIEIVP | 151 | Q9Y6J8 | |
| NIDEQLPVLEYPQPG | 81 | Q9BR01 | |
| FLPEGYPLPLDLEQQ | 56 | Q13905 | |
| LPPDNENKILPFQYV | 56 | Q12800 | |
| NQPDQKYDEENLPIP | 411 | O60281 | |
| YLNVPEEQDQKSPPI | 801 | Q8TBZ2 | |
| PLVEQPEDYTLQVNG | 231 | O00329 | |
| DPPPPDHQNGIIQEY | 761 | Q9HCK4 | |
| QYQLKQELPPEEQGP | 946 | O14795 | |
| IYPDPELEVQVLGLP | 66 | Q9BUZ4 | |
| KPVYAQVGQPDVDLP | 386 | Q07157 | |
| QPQPVDGVFVYPLAE | 41 | Q8N398 | |
| MNPQLGYEEQQPEVP | 1516 | Q6ZT12 | |
| ENNEDYEIPPITPPN | 71 | Q96NM4 | |
| LQETYDVCEQPPPLN | 121 | Q92558 | |
| PALEPQPQGNVPYLE | 251 | Q96LC7 | |
| PAEYEVINQFQPPPA | 221 | O75204 | |
| QYPNPLPVLSGAELE | 396 | Q96JC1 | |
| EIYGEPQTVLQNPPK | 1196 | Q9NZM1 | |
| ALPTDGPYLQILEQP | 36 | P19838 |